JPRN-UMIN000025784Completed未知
Safety and efficacy of Grazoprevir and Elbasvir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infection - Grazoprevir/Elbasvir therapy for hemodialyzed patients
Graduate School of Medicine, Hokkaido University0 sites60 target enrollmentStarted: January 21, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Patients with a past history of hypersensitivity to HCV protease inhibitors and NS5A inhibitors 2 Patients with serious liver dysfunction (Child-Pugh Class B or C) 3 Patients with difficult-to-control heart disease (e.g., myocardial infarction, heart failure, and arrhythmia) 4 Patients who have malignant tumors, including hepatoma, at the start of treatment 5 Patients on treatment with drugs listed in the contraindications for coadministration in the package insert (e.g., some antifungals, some antiepileptics, and human immunodeficiency virus (HIV) protease inhibitors) 6 Patients with albumin <3.0 g/dL 7 Other patients judged to be inappropriate to participate in the study by the primary physician
Investigators
Similar Trials
Recruiting
Not Applicable
Efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis CJPRN-UMIN000025050Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
Completed
Not Applicable
Prospective study of Grazoprevir and Elbasvir for HCV genotype 1 intected Japanese patientsHCV genotype 1 infected chronic liver diseaseJPRN-UMIN000025191Osaka City University and affiliated hospital119
Completed
Phase 4
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infectionChronic Hepatitis CNCT03098121Taoyuan General Hospital40
Recruiting
Not Applicable
Evaluation of the efficacy of elbasvir and glazopurevir for Japanese hepatitis C patients: a prospective study in real life settings.JPRN-UMIN000026908Toranomon Hospital100
Completed
Not Applicable
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hepatitis C infected patients with chronic hepatitis or liver cirrhosisJPRN-UMIN000031090Hokkaido University Hospital300